PharmaEssentia Statistics

Total Valuation

PharmaEssentia has a market cap or net worth of TWD 176.01 billion. The enterprise value is 154.96 billion.

Market Cap	176.01B
Enterprise Value	154.96B

Important Dates

The last earnings date was Monday, May 12, 2025.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

PharmaEssentia has 332.73 million shares outstanding. The number of shares has increased by 1.10% in one year.

Current Share Class	332.73M
Shares Outstanding	332.73M
Shares Change (YoY)	+1.10%
Shares Change (QoQ)	-0.18%
Owned by Insiders (%)	8.78%
Owned by Institutions (%)	8.47%
Float	261.64M

Valuation Ratios

The trailing PE ratio is 45.34 and the forward PE ratio is 25.98.

PE Ratio	45.34
Forward PE	25.98
PS Ratio	15.52
PB Ratio	6.04
P/TBV Ratio	6.10
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 48.97, with an EV/FCF ratio of 52.24.

EV / Earnings	39.75
EV / Sales	13.67
EV / EBITDA	48.97
EV / EBIT	54.88
EV / FCF	52.24

Financial Position

The company has a current ratio of 9.07, with a Debt / Equity ratio of 0.03.

Current Ratio	9.07
Quick Ratio	8.48
Debt / Equity	0.03
Debt / EBITDA	0.31
Debt / FCF	0.33
Interest Coverage	125.64

Financial Efficiency

Return on equity (ROE) is 14.56% and return on invested capital (ROIC) is 6.34%.

Return on Equity (ROE)	14.56%
Return on Assets (ROA)	5.86%
Return on Invested Capital (ROIC)	6.34%
Return on Capital Employed (ROCE)	9.39%
Revenue Per Employee	86.55M
Profits Per Employee	29.76M
Employee Count	131
Asset Turnover	0.38
Inventory Turnover	0.94

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +23.02% in the last 52 weeks. The beta is -0.10, so PharmaEssentia's price volatility has been lower than the market average.

Beta (5Y)	-0.10
52-Week Price Change	+23.02%
50-Day Moving Average	510.70
200-Day Moving Average	610.81
Relative Strength Index (RSI)	57.46
Average Volume (20 Days)	2,077,958

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PharmaEssentia had revenue of TWD 11.34 billion and earned 3.90 billion in profits. Earnings per share was 11.67.

Revenue	11.34B
Gross Profit	9.99B
Operating Income	2.82B
Pretax Income	4.12B
Net Income	3.90B
EBITDA	2.94B
EBIT	2.82B
Earnings Per Share (EPS)	11.67

Full Income Statement

Balance Sheet

The company has 22.03 billion in cash and 984.94 million in debt, giving a net cash position of 21.05 billion or 63.26 per share.

Cash & Cash Equivalents	22.03B
Total Debt	984.94M
Net Cash	21.05B
Net Cash Per Share	63.26
Equity (Book Value)	29.12B
Book Value Per Share	87.45
Working Capital	23.93B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.91 billion and capital expenditures -945.22 million, giving a free cash flow of 2.97 billion.

Operating Cash Flow	3.91B
Capital Expenditures	-945.22M
Free Cash Flow	2.97B
FCF Per Share	8.92

Full Cash Flow Statement

Margins

Gross margin is 88.12%, with operating and profit margins of 24.90% and 34.38%.

Gross Margin	88.12%
Operating Margin	24.90%
Pretax Margin	36.34%
Profit Margin	34.38%
EBITDA Margin	25.91%
EBIT Margin	24.90%
FCF Margin	26.16%

Dividends & Yields

This stock pays an annual dividend of 1.10, which amounts to a dividend yield of 0.21%.

Dividend Per Share	1.10
Dividend Yield	0.21%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.10%
Shareholder Yield	-0.89%
Earnings Yield	2.22%
FCF Yield	1.69%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PharmaEssentia has an Altman Z-Score of 31.

Altman Z-Score	31
Piotroski F-Score	n/a